Mouse Anti-DNMT3B Recombinant Antibody (15B83) (CBMAB-D1428-YC)

Name: Mouse Anti-DNMT3B Recombinant Antibody (15B83)
SKU: CBMAB-D1428-YC
Rating: 5 (1 reviews)

See all DNMT3B antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

15B83

Application

ICC, IF, IHC-Fr, IP, WB

Immunogen

Recombinant protein corresponding to mouse DNMT3b, expressed in bacteria

Specificity

Human, Mouse

Antibody Isotype

IgG

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage

Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

DNA Methyltransferase 3 Beta

Introduction

DNMT3B is a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. DNMT3B localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in DNMT3B cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome.

Entrez Gene ID

Human	1789
Mouse	13436

UniProt ID

Human	Q9UBC3
Mouse	O88509

Alternative Names

DNA Methyltransferase 3 Beta; DNA (Cytosine-5-)-Methyltransferase 3 Beta; DNA Methyltransferase HsaIIIB; DNA MTase HsaIIIB; EC 2.1.1.37; M.HsaIIIB;

Function

Required for genome-wide de novo methylation and is essential for the establishment of DNA methylation patterns during development. DNA methylation is coordinated with methylation of histones. May preferentially methylates nucleosomal DNA within the nucleosome core region. May function as transcriptional co-repressor by associating with CBX4 and independently of DNA methylation. Seems to be involved in gene silencing (By similarity).

In association with DNMT1 and via the recruitment of CTCFL/BORIS, involved in activation of BAG1 gene expression by modulating dimethylation of promoter histone H3 at H3K4 and H3K9. Isoforms 4 and 5 are probably not functional due to the deletion of two conserved methyltransferase motifs. Functions as a transcriptional corepressor by associating with ZHX1. Required for DUX4 silencing in somatic cells (PubMed:27153398).

Biological Process

Cellular response to dexamethasone stimulus Source: Ensembl
Cellular response to hyperoxia Source: Ensembl
DNA methylation Source: UniProtKB
Negative regulation of histone H3-K9 methylation Source: UniProtKB
Negative regulation of transcription by RNA polymerase II Source: UniProtKB
Positive regulation of gene expression Source: UniProtKB
Positive regulation of histone H3-K4 methylation Source: UniProtKB
Positive regulation of neuron differentiation Source: Ensembl
Response to activity Source: Ensembl
Response to caffeine Source: Ensembl
Response to cocaine Source: Ensembl
Response to drug Source: Ensembl
Response to estradiol Source: Ensembl
Response to hypoxia Source: Ensembl
Response to ionizing radiation Source: Ensembl
Response to toxic substance Source: Ensembl
Response to vitamin A Source: Ensembl

Cellular Location

Nucleus

Involvement in disease

Immunodeficiency-centromeric instability-facial anomalies syndrome 1 (ICF1):
A rare disorder characterized by a variable immunodeficiency resulting in recurrent infections, facial anomalies, and branching of chromosomes 1, 9, and 16. Other variable symptoms include growth retardation, failure to thrive, and psychomotor retardation. Laboratory studies show limited hypomethylation of DNA in a small fraction of the genome in some, but not all, patients.
Facioscapulohumeral muscular dystrophy 2 (FSHD2):
The gene represented in this entry may act as a disease modifier. DNMT3B mutations lead to DUX4 expression in somatic tissues, including muscle cells, when an haplotype on chromosome 4 is permissive for DUX4 expression. Ectopic expression of DUX4 in skeletal muscle activates the expression of stem cell and germline genes, and, when overexpressed in somatic cells, DUX4 can ultimately lead to cell death. A degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles.

PTM

Sumoylated.
Citrullinated by PADI4.

Zhu, L., Jia, L., Liu, N., Wu, R., Guan, G., Hui, R., ... & Wang, J. (2022). DNA Methyltransferase 3b Accelerates the Process of Atherosclerosis. Oxidative medicine and cellular longevity, 2022.

Qin, W., Brands, X., Van’t Veer, C., F. de Vos, A., Sirard, J. C., JTH Roelofs, J., ... & Van Der Poll, T. (2021). Bronchial epithelial DNA methyltransferase 3b dampens pulmonary immune responses during Pseudomonas aeruginosa infection. PLoS pathogens, 17(4), e1009491.

Yan, Y., He, Y. Y., Jiang, X., Wang, Y., Chen, J. W., Zhao, J. H., ... & Jing, Z. C. (2020). DNA methyltransferase 3B deficiency unveils a new pathological mechanism of pulmonary hypertension. Science Advances, 6(50), eaba2470.

Lin, C. C., Chen, Y. P., Yang, W. Z., Shen, J. C., & Yuan, H. S. (2020). Structural insights into CpG-specific DNA methylation by human DNA methyltransferase 3B. Nucleic acids research, 48(7), 3949-3961.

Iguchi, E., Takai, A., Takeda, H., Kumagai, K., Arasawa, S., Eso, Y., ... & Seno, H. (2020). DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis. Scientific reports, 10(1), 1-15.

Su, J. F., Zhao, F., Gao, Z. W., Hou, Y. J., Li, Y. Y., Duan, L. J., ... & Zhou, F. Y. (2020). piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B. Pathology-Research and Practice, 216(4), 152848.

Shiah, S. G., Hsiao, J. R., Chang, H. J., Hsu, Y. M., Wu, G. H., Peng, H. Y., ... & Chang, J. Y. (2020). MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer. Journal of biomedical science, 27(1), 1-13.

Zo, R. B., & Long, Z. (2019). MiR‐124‐3p suppresses bladder cancer by targeting DNA methyltransferase 3B. Journal of cellular physiology, 234(1), 464-474.

Shen, J., Wang, C., Li, D., Xu, T., Myers, J., Ashton, J. M., ... & O’Keefe, R. J. (2017). DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism. JCI insight, 2(12).

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-DNMT3B Recombinant Antibody (15B83)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-DNMT3B Recombinant Antibody (CBT2698) (CAT#: V2LY-0625-LY351)

Rabbit Anti-DNMT3B Recombinant Antibody (EG982) (CAT#: V2LY-0425-LY735)

Mouse Anti-DNMT3B Recombinant Antibody (D1432) (CAT#: V2LY-0425-LY733)

Rabbit Anti-DNMT3B Recombinant Antibody (E9X7R) (CAT#: CBMAB-CP0488-LY)

Mouse Anti-DNMT3B Recombinant Antibody (4D1A2E5) (CAT#: CBMAB-D1430-YC)

Human Anti-DNMT3B Recombinant Antibody (D1428) (CAT#: V2LY-0425-LY729)

Mouse Anti-DNMT3B Recombinant Antibody (D1430) (CAT#: V2LY-0425-LY731)

Mouse Anti-DNMT3B Recombinant Antibody (52A1018) (CAT#: V2LY-0425-LY732)

Mouse Anti-DNMT3B Recombinant Antibody (CBT2706) (CAT#: V2LY-0625-LY352)

Mouse Anti-DNMT3B Recombinant Antibody (2280C3a) (CAT#: CBMAB-D1429-YC)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry